Japanese Encephalitis - PubMed (original) (raw)

Book

In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan.

2023 Aug 28.

Affiliations

PMID: 29262148
Bookshelf ID: NBK470423

Free Books & Documents

Book

Japanese Encephalitis

Leslie V. Simon et al.

Free Books & Documents

Excerpt

Japanese encephalitis is the most common preventable cause of mosquito-borne encephalitis in Asia, Australia, and the western Pacific. The Culex species of mosquitoes transmit the virus with their bite. Transmission occurs most commonly in agricultural areas such as farms and rice paddies but may occur in urban areas under certain conditions. While the vast majority of infections are asymptomatic, those who do develop symptoms of encephalitis suffer significant morbidity and mortality. Symptomatic patients develop a high fever, headache, disorientation, coma, tremors and mental status changes due to cerebral inflammation. Movement disorders, neurologic deficits, and seizures are common, particularly in children. Approximately one in four symptomatic cases are fatal. Children are most commonly affected, and most people who reside in endemic areas will have immunity by adulthood. There is no specific therapy beyond supportive care, but there is an effective vaccine available to prevent infection. The vaccine is recommended for high-risk travelers to endemic areas. Many endemic areas have implemented childhood vaccination programs. The best protection is the prevention of mosquito bites.

PubMed Disclaimer

Conflict of interest statement

Disclosure: Leslie Simon declares no relevant financial relationships with ineligible companies.

Disclosure: Divyajot Sandhu declares no relevant financial relationships with ineligible companies.

Disclosure: Amandeep Goyal declares no relevant financial relationships with ineligible companies.

Disclosure: Brian Kruse declares no relevant financial relationships with ineligible companies.

Sections

References

1. Muniaraj M, Rajamannar V. Impact of SA 14-14-2 vaccination on the occurrence of Japanese encephalitis in India. Hum Vaccin Immunother. 2019;15(4):834-840. - PMC - PubMed
1. Houle SKD, Eurich DT. Completion of multiple-dose travel vaccine series and the availability of pharmacist immunizers: A retrospective analysis of administrative data in Alberta, Canada. PLoS One. 2019;14(1):e0211006. - PMC - PubMed
1. Chai C, Palinski R, Xu Y, Wang Q, Cao S, Geng Y, Zhao Q, Wen Y, Huang X, Yan Q, Ma X, Wen X, Huang Y, Han X, Ma W, Wu R. Aerosol and Contact Transmission Following Intranasal Infection of Mice with Japanese Encephalitis Virus. Viruses. 2019 Jan 21;11(1) - PMC - PubMed
1. Vasanthapuram R, Shahul Hameed SK, Desai A, Mani RS, Reddy V, Velayudhan A, Yadav R, Jain A, Saikia L, Borthakur AK, Mohan DG, Bandyopadhyay B, Bhattacharya N, Dhariwal AC, Sen PK, Venkatesh S, Prasad J, Laserson K, Srikantiah P. Dengue virus is an under-recognised causative agent of acute encephalitis syndrome (AES): Results from a four year AES surveillance study of Japanese encephalitis in selected states of India. Int J Infect Dis. 2019 Jul;84S:S19-S24. - PubMed
1. Fang Y, Zhang Y, Zhou ZB, Xia S, Shi WQ, Xue JB, Li YY, Wu JT. New strains of Japanese encephalitis virus circulating in Shanghai, China after a ten-year hiatus in local mosquito surveillance. Parasit Vectors. 2019 Jan 09;12(1):22. - PMC - PubMed